ACULA TECHNOLOGY CORP.

Clinical/ Diagnostic/ Surgical Medical Monitors
(19" | 21.5" | 21.3" | 27")

Acura Nanomedicine Inc.

Anti “Drug Resistant” Cancer Drug: AN-845
Acura Nanomed. has developed successfully an anti-cancer drug: AN-845, which is a combination of two generic drugs. AN-845 has the ability to completely suppress the growth of “drug-resistant pancreatic cancer”, no matter in cell based experiments (in vitro) or in animal tests (in vivo). AN-845 also can strongly inhibit the proliferation of liver cancer (HCC) and brain cancer (GBM) …etc. AN-845 has high safety profile due to the all ingredients have been used in human for decades and already have complete reports of PK/PD/Toxicity data. AN-845 can be developed by following two “fast-track” regulations (505(b)2 & orphan drug) at the same time. By this reason, AN-845 can be developed accelerated and get the first NDA approve (for pancreatic cancer) plus licensing out within 3 years after finish a single phase I/IIA pivotal clinical study.
Modular Design High Efficacy Tumor Targeting Nano-vehicle Platform
Another advanced technology platform of Acura Nanomedicine is “Modular Design High Efficacy Tumor Targeting Nano-vehicle Platform”. The manufacturing process is an extremely fast one-pot synthesis process, Acura Nanomed. can obtain one batch product within 25 minutes with greater than 95% drug encapsulation efficiency and near 100% final yield. The Acura Nanomed.’s nanomedicine will provide extremely high affinity to target cells, for example, 80~100 times delivery efficacy compare to the traditional nanovehicle.

AcuSense BioMedical Technology Corp

Acusense Biomedical was founded in 2017, with a focus on development of medical devices and the core proposition to make medical environment safer. Sensing the rising need in patient safety, risk management of hospital, and increasing number of hemodialysis patients, we cut in the market with intradialytic blood leakage alarm , and become the first company in Taiwan with the core technology to detect blood leakage caused by slipping needle.

Our first developing product－\\\"Blood Leakage Detecting Patch\\\", aims the trend of smart care and home hemodialysis. And it follows the requirements of IEC/PAS 63023 to communicate with the interface of hemodialysis machine in corresponding protocol, greatly lowering the clinical risk and the number of unnecessary medical disputes.

Second product-\\\"Re-Minder Smart Tourniquet\\\, a buzzer warning smart tourniquet; it is suitable for inpatient ward injections, blood draws, home, personal hemodialysis hemostatic scenarios, used to remind the user of when to remove the tourniquet, and has Waterproof and dustproof, easy to use and other related features.

The third product "Hemera"-an optical sensor leakage detection device, uses multi-band optical sensing technology to accurately detect leakage signals under the skin, which can solve chemotherapy leakage and acute and severe infusion.

ADISON BIOTECHNOLOGY CO., LTD

Vein Visualizer(血管顯像儀)，Medical Mask(醫用口罩)， Medical Protective Clothing(防護衣)。

ADLINK Technology INC.

Clinical imaging modalities are essential tools in the healthcare arena and are mandatory within the surgical field. It is similarly important for physicians to see pristine images in high quality as it is for the safety that the medical devices offer a maximum in terms of hygiene. The medically certified ASM Series surgical monitor offers hygienic design and pristine images for better intensive care. The features of ASM series includes:
 Hygienic design prevents the spread of infection: Allow for easy cleaning by medical care teams after use, prevent bacterial growth in cracks, and shorten operating room turnover time. The hygienic design includes a screwless, fully-sealed housing, edge-to-edge touch panel (no frame), on-screen buttons (no physical buttons), antibacterial surface coating, and IP54 protection.
 Produce pristine images: Allow doctors to see the smallest details when treating patients, which is essential when they perform surgery, investigate patient symptoms, take biopsies, and treat lesions.
 Increased Safety: ASM series is IEC/EN-60601-1 and IEC/EN-60601-1-2 certified. These certifications protect the safety of those operating the medical devices and prevent the devices from interfering with one another in operating rooms and ICUs, which help ensure the safety of the operating room staff and patients.

Advanced Biomedical Technology

Our product, MeDFila® has been approved by the FDA. Different composition of specific polymer & polymer/ceramic filaments can use in a wide range of medical needs, including dental fillings, cranial repairs, drug delivery, tissue engineering, and so on. We also collaborate with doctors and find out the best way to link customization service to the hospital. According to medical-grade material, service for medical 3D printing applications, and the image modeling of an implant, we could quickly and accurately provide the medical implant printing service to clients.

Advantech

Advantech provide the iward solution and telehealth solution. The intelligent ward allow faster communication of patient's needs to the nursing staff and facilitates an innovative nursing care SOP that improves serve quality as well as patient satisfaction through the system.

Aesthetic Medical Center, Cheng Hsin General Hospital

The principle of treatment for ptosis is mainly surgical operation. In eyelid ptosis surgery, the treatment of severe blepharoptosis is the most difficult. This operation can be traced back to the frontalis muscle suspension method. But after the operation, there are often problems that the eyes cannot be closed completely, and even the problem of ptosis eyelids cannot be solved.
For the treatment of severe blepharoptosis, how to lift the severely ptosis eyelid to a normal position while avoiding the postoperative lagophthalmos caused by another problem is indeed a difficult challenge. Based on the anatomical structure of the eye, the author used surface electromyography to measure the changes in the muscles around the eye after surgery for normal people and patients with ptosis eyelids. Research on this concept has been published in international journals of electromyography and human kinematics. Based on the foregoing analysis, the author proposes to dissect the levator muscle transconjunctiva incision and move it down to the upper edge of the tarsal plate with the reinforced suspension of the conjoint fascia sheath to the tarsal plate. This surgical method is completely scarless, not only the severe blepharoptosis is corrected, all of the lagophthalmos if happened after operation is completely resolved with one month.

Aether Services, Taiwan, Ltd.

Intelligent environmental intervention products and precision health program of allergic respiratory healthcare

aetherAI Co., Ltd

AI-Powered Digital Pathology Workflow System, AI-Powered Diagnostic Support Applications